Intravitreal injection of bevacizumab was effective in two cases of Irvine-Gass syndrome

Yukari Shirakata, Chieko Shiragami, Hiroyuki Nomoto, Takashi Fujimura, Fumio Shiraga

Research output: Contribution to journalArticle

Abstract

Purpose : To report two cases of Irvine-Gass syndrome that responded to intravitreal injection of bevacizumab. Cases and Findings : Two males, aged 73 and 69 years, received phacoemulsification with intraocular lens implantation. Visual acuity improved to 0.8 and 1.2 but decreased to 0.2 and 0.6 after 3 weeks and 2 months respectively. Both cases showed cystoid macular edema (CME) and thickened fovea, leading to the diagnosis of Irvine-Gass syndrome. Intravitreal injection of bevacizumab was followed by resolution of CME after 2 and 1 week respectively. Visual acuity improved to 0.4 and 1.2 respectively. There has been no recurrence for 13 and 22 months until present. Conclusion : Intravitreal injection of bevacizumab may be effective for Irvine-Gass syndrome.Rinsho Ganka (Jpn J Clin Ophthalmol) 63(5): 801-805, 2009.

Original languageEnglish
Pages (from-to)801-805
Number of pages5
JournalJapanese Journal of Clinical Ophthalmology
Volume63
Issue number5
Publication statusPublished - 2009
Externally publishedYes

Fingerprint

Intravitreal Injections
Macular Edema
Visual Acuity
Intraocular Lens Implantation
Phacoemulsification
Bevacizumab
Recurrence

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Intravitreal injection of bevacizumab was effective in two cases of Irvine-Gass syndrome. / Shirakata, Yukari; Shiragami, Chieko; Nomoto, Hiroyuki; Fujimura, Takashi; Shiraga, Fumio.

In: Japanese Journal of Clinical Ophthalmology, Vol. 63, No. 5, 2009, p. 801-805.

Research output: Contribution to journalArticle

Shirakata, Yukari ; Shiragami, Chieko ; Nomoto, Hiroyuki ; Fujimura, Takashi ; Shiraga, Fumio. / Intravitreal injection of bevacizumab was effective in two cases of Irvine-Gass syndrome. In: Japanese Journal of Clinical Ophthalmology. 2009 ; Vol. 63, No. 5. pp. 801-805.
@article{f120f7441ae34896b66b7945ce12c694,
title = "Intravitreal injection of bevacizumab was effective in two cases of Irvine-Gass syndrome",
abstract = "Purpose : To report two cases of Irvine-Gass syndrome that responded to intravitreal injection of bevacizumab. Cases and Findings : Two males, aged 73 and 69 years, received phacoemulsification with intraocular lens implantation. Visual acuity improved to 0.8 and 1.2 but decreased to 0.2 and 0.6 after 3 weeks and 2 months respectively. Both cases showed cystoid macular edema (CME) and thickened fovea, leading to the diagnosis of Irvine-Gass syndrome. Intravitreal injection of bevacizumab was followed by resolution of CME after 2 and 1 week respectively. Visual acuity improved to 0.4 and 1.2 respectively. There has been no recurrence for 13 and 22 months until present. Conclusion : Intravitreal injection of bevacizumab may be effective for Irvine-Gass syndrome.Rinsho Ganka (Jpn J Clin Ophthalmol) 63(5): 801-805, 2009.",
author = "Yukari Shirakata and Chieko Shiragami and Hiroyuki Nomoto and Takashi Fujimura and Fumio Shiraga",
year = "2009",
language = "English",
volume = "63",
pages = "801--805",
journal = "Japanese Journal of Clinical Ophthalmology",
issn = "0370-5579",
publisher = "Igaku-Shoin Ltd",
number = "5",

}

TY - JOUR

T1 - Intravitreal injection of bevacizumab was effective in two cases of Irvine-Gass syndrome

AU - Shirakata, Yukari

AU - Shiragami, Chieko

AU - Nomoto, Hiroyuki

AU - Fujimura, Takashi

AU - Shiraga, Fumio

PY - 2009

Y1 - 2009

N2 - Purpose : To report two cases of Irvine-Gass syndrome that responded to intravitreal injection of bevacizumab. Cases and Findings : Two males, aged 73 and 69 years, received phacoemulsification with intraocular lens implantation. Visual acuity improved to 0.8 and 1.2 but decreased to 0.2 and 0.6 after 3 weeks and 2 months respectively. Both cases showed cystoid macular edema (CME) and thickened fovea, leading to the diagnosis of Irvine-Gass syndrome. Intravitreal injection of bevacizumab was followed by resolution of CME after 2 and 1 week respectively. Visual acuity improved to 0.4 and 1.2 respectively. There has been no recurrence for 13 and 22 months until present. Conclusion : Intravitreal injection of bevacizumab may be effective for Irvine-Gass syndrome.Rinsho Ganka (Jpn J Clin Ophthalmol) 63(5): 801-805, 2009.

AB - Purpose : To report two cases of Irvine-Gass syndrome that responded to intravitreal injection of bevacizumab. Cases and Findings : Two males, aged 73 and 69 years, received phacoemulsification with intraocular lens implantation. Visual acuity improved to 0.8 and 1.2 but decreased to 0.2 and 0.6 after 3 weeks and 2 months respectively. Both cases showed cystoid macular edema (CME) and thickened fovea, leading to the diagnosis of Irvine-Gass syndrome. Intravitreal injection of bevacizumab was followed by resolution of CME after 2 and 1 week respectively. Visual acuity improved to 0.4 and 1.2 respectively. There has been no recurrence for 13 and 22 months until present. Conclusion : Intravitreal injection of bevacizumab may be effective for Irvine-Gass syndrome.Rinsho Ganka (Jpn J Clin Ophthalmol) 63(5): 801-805, 2009.

UR - http://www.scopus.com/inward/record.url?scp=67949089831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67949089831&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:67949089831

VL - 63

SP - 801

EP - 805

JO - Japanese Journal of Clinical Ophthalmology

JF - Japanese Journal of Clinical Ophthalmology

SN - 0370-5579

IS - 5

ER -